Simplex Trading’s Orchestra BioMed OBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.64K Sell
746
-1,818
-71% -$8.72K ﹤0.01% 8157
2026
Q2
$11.1K Buy
2,564
+183
+8% +$748 ﹤0.01% 7608
2026
Q1
$10.1K Buy
+2,381
New +$10.1K ﹤0.01% 7350
2025
Q4
– Sell
-324
Closed -$1.31K – 9620
2025
Q3
$0 Buy
+324
New +$894 ﹤0.01% 9758

Other funds holding OBIO

Simplex Trading's OBIO Position: Q3 2026 in Review

Simplex Trading reduced its Orchestra BioMed (OBIO) stake by 71% in Q3 2026, selling an estimated $8.72K and leaving 746 shares worth $4.64K. The position accounts for ﹤0.01% of the portfolio, ranked #8157.

Simplex Trading first reported a position in OBIO in Q3 2025 and has held it in 4 quarters since. The position peaked at $11.1K in Q2 2026. 91 funds tracked by Wall St. Rank hold OBIO as of Q3 2026.

  • Simplex Trading held 746 shares of Orchestra BioMed worth $4.64K as of Q3 2026.
  • Simplex Trading sold 1,818 Orchestra BioMed shares in Q3 2026, an estimated $8.72K.
  • Orchestra BioMed made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #8157 holding.
  • Simplex Trading first reported a position in Orchestra BioMed in Q3 2025 and has held it in 4 quarters since.
  • Simplex Trading's Orchestra BioMed position peaked at $11.1K in Q2 2026.
  • 91 funds tracked by Wall St. Rank held Orchestra BioMed as of Q3 2026.

Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.